Paraneoplastic hyponatremia

Name	Development Level	Target Family

Name	Description
mozavaptan	aquaretic agent; vasopressin V2 receptor antagonist; structure given in first source

TCRDv4.6.9
DrugCentral Indication
DrugCentral
mozavaptan